Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) EBIT Margin (2018 - 2026)

Viemed Healthcare filings provide 8 years of EBIT Margin readings, the most recent being 10.99% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 36.0% to 10.99% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.49%, a 51.0% increase, with the full-year FY2025 number at 8.49%, up 51.0% from a year prior.
  • EBIT Margin hit 10.99% in Q4 2025 for Viemed Healthcare, up from 7.85% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 14.6% in Q4 2021 to a low of 3.01% in Q2 2022.
  • Median EBIT Margin over the past 5 years was 7.96% (2025), compared with a mean of 7.88%.
  • Biggest five-year swings in EBIT Margin: plummeted -2028bps in 2021 and later skyrocketed 441bps in 2023.
  • Viemed Healthcare's EBIT Margin stood at 14.6% in 2021, then crashed by -35bps to 9.42% in 2022, then grew by 11bps to 10.42% in 2023, then grew by 2bps to 10.63% in 2024, then grew by 3bps to 10.99% in 2025.
  • The last three reported values for EBIT Margin were 10.99% (Q4 2025), 7.85% (Q3 2025), and 8.08% (Q2 2025) per Business Quant data.